IVF Embryo Selection Now Weighs Future Health, Not Just Genes
New method could save your future child from diseases and save you money.
When couples use IVF, they can choose embryos based on genetic tests that predict risk for diseases like cancer and heart disease. Companies like Herasight and Genomic Prediction offer an 'embryo health score' that combines these risks into one number. But the author, who is planning to use this technology, points out a flaw: the score doesn't account for the fact that medical progress will likely make many diseases treatable in the future. For example, a child born in 2027 with a high risk of heart disease might not develop it until middle age, by which time treatments could be much better.
The author suggests adjusting the scores using a concept from economics called discounting, which gives less weight to future health problems. Health economists often use a 3% annual discount rate, and the author applies this to the embryo health scores. This means that late-onset conditions like Alzheimer's are weighted less than early-onset ones like schizophrenia, because the latter affects more of a person's life. The author also assumes that medical progress will be faster for some conditions than others, further reducing the weight of those diseases.
The cost of embryo selection is about $500 per embryo, plus IVF costs around $7,500 per cycle. The author estimates that the side effects of hormone stimulation cause a loss of 0.025 disability-adjusted life years (DALYs) per cycle. But these costs are small compared to the burden of the diseases that selection can prevent. The author argues that even with discounting, embryo selection is a worthwhile investment in a child's future health.
Overall, the piece is a call to improve how embryo health scores are calculated, making them more realistic about future medical advances. For parents using IVF, this could mean better-informed choices and healthier children. For society, it could lead to more efficient use of healthcare resources. The author's personal experience adds a relatable touch to a complex topic.
- Embryo health scores currently ignore future medical progress, which could make some diseases less threatening by the time they appear.
- Discounting future health problems at 3% per year would prioritize early-onset conditions like schizophrenia over late-onset ones like Alzheimer's.
- The cost of embryo selection is small compared to the potential health benefits, but the scoring method needs improvement.
Why It Matters
For IVF parents, better embryo scoring could mean healthier children and smarter spending on fertility treatments.